Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Gastric Cancer
Published in: Gastric Cancer 4/2000

01-12-2000 | Case report

Advanced gastric glandular-endocrine cell carcinoma with 1-year survival after gastrectomy

Authors: Hiroyuki Matsubayashi, Shinichi Takagaki, Takao Otsubo, Takao Iiri, Yuka Kobayashi, Takashi Yokota, Kimitoshi Shichijo, Tetsuya Tada, Keiichi Satoh, Mitsuya Iwafuchi

Published in: Gastric Cancer | Issue 4/2000

Login to get access
Metadata
Title
Advanced gastric glandular-endocrine cell carcinoma with 1-year survival after gastrectomy
Authors
Hiroyuki Matsubayashi
Shinichi Takagaki
Takao Otsubo
Takao Iiri
Yuka Kobayashi
Takashi Yokota
Kimitoshi Shichijo
Tetsuya Tada
Keiichi Satoh
Mitsuya Iwafuchi
Publication date
01-12-2000
Publisher
Springer-Verlag
Published in
Gastric Cancer / Issue 4/2000
Print ISSN: 1436-3291
Electronic ISSN: 1436-3305
DOI
https://doi.org/10.1007/PL00011721

Other articles of this Issue 4/2000

Gastric Cancer 4/2000 Go to the issue

Original article

Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers

Original article

Prognostic factors in patients with advanced gastric cancer with macroscopic invasion to adjacent organs treated with radical surgery

Original article

Gastric cancer with extragastric lymph node metastasis: multivariate prognostic study

Original article

Expression of transforming growth factor β (TGF-β) may contribute, in part, to the variations in histogenesis and the prevalence of peritoneal dissemination in human gastric carcinoma

Original article

Evaluation of serum CEA and CA19-9 levels as prognostic factors in patients with gastric cancer

Original article

Clinical significance of disordered beta-catenin expression pattern in human gastric cancers
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits